Share this post on:

Product Name :
PTX-008

Search keywords :
OTX008

drugId :
null

Target Vo:
Galectin-1

Target Vo Short Name :
Gal-1

Moa_Name:
Galectin-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Peptx

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Solid tumours

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JunB Rabbit mAb site
TrkA Rabbit mAb Purity & Documentation
AKT1 Antibody (YA834): AKT1 Antibody (YA834) is a non-conjugated and Mouse origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related